Randomized Controlled Trial Comparing Efficacy of Sorafenib Versus Sorafenib In Combination With Low Dose Cisplatin /Fluorouracil Hepatic Arterial InfUSion Chemotherapy in Patients With Advanced Hepatocellular Carcinoma.
Phase of Trial: Phase III
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Cisplatin (Primary) ; Fluorouracil (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SILIUS
- 22 Mar 2017 Status changed from recruiting to completed.
- 17 Apr 2016 Primary endpoint (overall survival) has not been met, according to Results presented at The International Liver Congress 2016.
- 17 Apr 2016 Results presented at The International Liver Congress 2016.